The Lancet Infectious Diseases, 17 (2), February 2017 Abstract: Antimicrobial resistance in Neisseria gonorrhoeae is recognised globally as a public health threat. Dual therapy with ceftriaxone and azithromycin has been introduced in Australia and elsewhere as the first-line treatment recommendation for gonorrhoea. While there have been only sporadic reports of ceftriaxone-resistant gonococci...
Treatment guidelines after an outbreak of azithromycin-resistant Neisseria gonorrhoeae in SA
T